A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

Name: A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
Creator: Hangzhou Instititute of Medicine
Published: 2024-06-22T15:41:41+08:00

integrated proteome resources2026-02-07 收录

癌细胞耐药性

药物靶点发现

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0009118000 数据链接链接失效反馈

官方服务：

资源简介：

A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

提供机构：

Hangzhou Instititute of Medicine

创建时间：

2024-06-22

A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

资源简介：

相关数据集